SRY LabsGHK-Cu
Ordered GHK-Cu from SRY Labs? Mail in a sample (US only) and let us test it for free.
Test my supplySRY Labs' GHK-Cu is pulled down by repeated large overfills, including +104% to +120% early fills and a later +97%, with one 99.32% purity miss. Identity passed, but volatile fills and mostly absent batch IDs make the evidence uneven.
We investigated who actually operates SRY Labs — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including SRY Labs rows.
Cancel anytime
About SRY Labs test results from Finnrick
SRY Labs is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 12 peptides and 130 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible SRY Labs peptides in this dataset are Tirzepatide (36 tests) and Retatrutide (32 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 130 recent tests.
Ordered GHK-Cu from SRY Labs? Mail in a sample (US only) and let us test it for free.
Test my supply